Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBI-001 Gel in Atopic Dermatitis
NCT05253755Phase 2Terminated
- Sponsor
- DermBiont, Inc.
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DBI-001 in atopic dermatitis (AD), sponsored by DermBiont, Inc.. Started Oct 2021; status: terminated.
02
Drugs
DBI-001
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05253755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05253755.